Trius Therapeutics, Inc.

Part of Cubist Pharmaceuticals, Inc.

UEI
MCPHH5DJ3GR6
CAGE
47YA5
Primary NAICS
541711 Research and Development in Biotechnology
SAM.gov registration
Deleted

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Contracts and Grants
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Website
cubist.com
Founded
1992
Employees
251-1K
Estimated annual revenue
$500M-$1B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Trius Therapeutics, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
"development of therapeutic medical countermeasures for biodefense and emerging infectious diseases" 09/16/13-… Contract · HHSN272201300018C NIAID DEA OA Acquisitions $845,876
Broad spectrum antibacterial therapeutics from marine natural products. Contract · HDTRA110C0004 Defense Threat Reduction Agency $7,272,905
New contract award under BAA NIH-niaid-dmid-08-20 Contract · HHSN272200800042C NIAID DEA OA Acquisitions $25,641,873
Identification of target-specific antimicrobials Grant · R03MH079846 National Institutes of Health $2,000
Novel bacterial cell wall biosynthesis inhibitors for biodefense therapeutics Grant · R43AI069666 National Institutes of Health $619,482

Quick answers

What is Trius Therapeutics, Inc.'s UEI?

Trius Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is MCPHH5DJ3GR6.

What is Trius Therapeutics, Inc.'s CAGE code?

Trius Therapeutics, Inc.'s CAGE code is 47YA5.

What is Trius Therapeutics, Inc.'s primary NAICS code?

Trius Therapeutics, Inc.'s primary NAICS code is 541711 (Research and Development in Biotechnology).

Is Trius Therapeutics, Inc. registered in SAM.gov?

Trius Therapeutics, Inc.'s SAM.gov registration was deleted on June 27, 2017.

Who is Trius Therapeutics, Inc.'s parent company?

Trius Therapeutics, Inc. is part of Cubist Pharmaceuticals, Inc.

What is Trius Therapeutics, Inc.'s most recent federal award?

Trius Therapeutics, Inc.'s most recent federal contract award is "development of therapeutic medical countermeasures for biodefense and emerging infectious diseases" 09/16/13-… (HHSN272201300018C), from NIAID DEA OA Acquisitions, on September 12, 2013.

On GovTribe

See Trius Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login